Know more, live better.
We’re dedicated to helping people live their best days by helping them better understand their genome with GENETICSNOW®
Guidance
Doctor - patient support
Family planning
Useful for future family planning
Early Intervention
Early diagnosis
Bringing solutions to genetic testing.
GoPath's GeneticsNow® Series includes a collection of next-generation sequencing panels that detect germline variants associated with an increased risk for various hereditary cancers. Our germline tests are clinical grade, with fast turnaround times and actionable results. We also have in-house certified genetic counselors to aid in interpretation of results and to provide guidance to patients.
Most hereditary cancers
This COMPREHENSIVE GERMLINE PANEL analyzes 88 clinically-relevant genes that are associated with genetic disorders, including most hereditary cancers.
Learn more
Prostate cancer
PROSTATENOW™ is a comprehensive germline test for people with prostate cancer. This test can be used to predict prognosis among men with localized prostate cancer, predict therapeutic responses for advanced patients, and predict cancer risk among unaffected men.
Learn more
Breast cancer
There is an increased likelihood of a BRCA1 or BRCA2 mutation in patients with certain personal and family history characteristics and various clinical criteria. BRCANOW® is a Next-Gen Sequencing (NGS)-based assay using a state-of-the-art platform to detect whether or not a mutation is present.
Learn more
Colon cancer
LYNCHNOW® is a cost-effective, comprehensive screening that rapidly detects mutations that causes Lynch syndrome.
Learn more
Our foundation is innovation.
We employ the best team, utilize the latest molecular technology and techniques, and build collaborations with key innovation partners.
Learn more